Raynaud F, Horvàth C
Laboratoire de Physiopathologie du Dévelopment, Université Pierre-et-Marie-Curie, Paris, France.
Reprod Nutr Dev. 1994;34(5):461-71. doi: 10.1051/rnd:19940507.
In order to establish a relationship between the appearance of congenital malformations and the decrease of folic acid in rat mothers and embryos, a folic acid antagonist, pyrimethamine (PY), was administered. On the 12th day of gestation/pregnant rats received an intraperitoneal injection of 12.5, 15.63, 18.75 or 25 mg/kg PY. On the 13th day of gestation folic acid was measured in different maternal and embryonic tissues obtained after surgical hysterectomy of 1 uterine horn. On the 21st day of gestation malformations were studied on live fetuses remaining in the opposite horn. The folate levels were identical in all maternal tissues. The concentration of folic acid significantly decreased (50%) within the embryonic tissues in all PY-treated groups. A decrease of fetal weight occurred in the 18.75 and 25 mg/kg PY groups. Malformations were observed in the same groups. A dysfunction of the placental transfer of folates is hypothesized.
为了建立先天性畸形的出现与大鼠母体和胚胎中叶酸减少之间的关系,给予了一种叶酸拮抗剂乙胺嘧啶(PY)。在妊娠第12天,给怀孕大鼠腹腔注射12.5、15.63、18.75或25mg/kg的PY。在妊娠第13天,对通过手术切除一个子宫角后获得的不同母体和胚胎组织中的叶酸进行测量。在妊娠第21天,对留在对侧子宫角中的活胎儿进行畸形研究。所有母体组织中的叶酸水平相同。在所有接受PY治疗的组中,胚胎组织中的叶酸浓度显著降低(50%)。在18.75和25mg/kg PY组中出现了胎儿体重下降。在相同组中观察到了畸形。推测存在叶酸胎盘转运功能障碍。